Pancreatic Cancer, Islet Cell Clinical Trials

• A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors.
  ClinicalTrials.gov Identifier: NCT00428597 - Recruiting
  Carcinoma, Islet Cell
  
• Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression
  ClinicalTrials.gov Identifier: NCT00530686 - Recruiting
  Islet Cell Transplantation; Type 1 Diabetes
  
• Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
  acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
  
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
  duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
  childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...
  
• Pancreatic Islet Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00214786 - Recruiting
  Islet Cell Transplantation
  
• 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005869 - Active, not recruiting
  recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004003 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer
  
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
  ClinicalTrials.gov Identifier: NCT00003125 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage III pancreatic cancer; stage IV breast cancer; stage IIIA non-small cell lung cancer; ...
  
• Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
  recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
  
• Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Phase I Study of Vaccination With MUC-1 Antigen and Immunologic Adjuvant SB AS-2 in Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00008099 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00088894 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00078975 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00033735 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00111904 - Recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003591 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
  
• Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005053 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
  
• DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003951 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004884 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
  ClinicalTrials.gov Identifier: NCT00085371 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004087 - Active, not recruiting
  recurrent colon cancer; recurrent pancreatic cancer; stage IV pancreatic cancer; Stage IV rectal cancer; recurrent rectal cancer; ...
  
• Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00363051 - Completed
  Islet Cell Carcinoma; Neuroendocrine Carcinoma; Neuroendocrine Tumor; Pancreatic Neoplasms
  
• Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00077519 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
  
• BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058149 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024375 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00075452 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
  
• Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
  stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
  
• Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003780 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; Quality of Life; stage II pancreatic cancer
  
• Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026338 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• 3-Dimensional Conformal Radiation Therapy, Arterial Embolization, and Tumor Cell Vaccine in Treating Patients With Unresectable, Recurrent, or Metastatic Primary Liver Cancer or Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00553683 - Recruiting
  Liver Cancer; Pancreatic Cancer
  
• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00325494 - Active, not recruiting
  Pancreatic Cancer; Mesothelioma; Ovarian Cancer; Non-Small Cell Lung Cancer
  
• Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00023972 - Active, not recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
  
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003677 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00082862 - Recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00323583 - Recruiting
  Adenocarincoma of Pancreas; Stage III Pancreatic Cancer; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer
  
• Study of the Efficacy and Safety of Glufosfamide Compared with Best Supportive Care in Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00099294 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004861 - Active, not recruiting
  stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
  ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
  adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
  
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003546 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer
  
• Flavopiridol in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00112684 - Recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; Pheochromocytoma; Thyroid Cancer
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00019786 - Active, not recruiting
  Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
  
• Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00084357 - Active, not recruiting
  Pancreatic Cancer
  
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00047307 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer
  
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00096070 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Islet Cell Transplant
  ClinicalTrials.gov Identifier: NCT00160732 - Recruiting
  Diabetes Mellitus, Type 1
  
• Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
  recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003514 - Recruiting
  Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
  
• MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00112580 - Recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas
  
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00243854 - Recruiting
  Pancreatic Cancer
  
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00004879 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; Prostate Cancer
  
• Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00064207 - Active, not recruiting
  adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00006117 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004190 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
  
• A Study to Test the Effectiveness of Virulizin® Given in Combination with Standard Chemotherapy for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00040092 - Active, not recruiting
  Pancreatic Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026403 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003332 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• 6-Hydroxymethylacylfulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003760 - Active, not recruiting
  recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00005594 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003049 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00126633 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00466856 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Neoplastic Syndrome; Pheochromocytoma
  
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026104 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
  ClinicalTrials.gov Identifier: NCT00322712 - Active, not recruiting
  Pancreatic Cancer
  
• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Safety and Efficacy of G17DT Immunogen in the Treatment of Advanced Pancreatic Carcinoma
  ClinicalTrials.gov Identifier: NCT00044031 - Active, not recruiting
  Pancreatic Cancer
  
• Study of TNFerade™ Biologic with 5-FU and Radiation Therapy for the Treatment of Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00051467 - Recruiting
  Pancreatic Cancer
  
• Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003434 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112658 - Recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026130 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Surgery in Treating Patients With Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00104832 - Recruiting
  recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
  
• LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00010270 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer